Renewing Pemazyre (Pemigatinib) Approval with UnitedHealthcare in Ohio: Complete 2025 Renewal Guide
Answer Box: Renewing Pemazyre with UnitedHealthcare in Ohio
UnitedHealthcare requires prior authorization renewal for Pemazyre (pemigatinib) every 12 months, with approval based on documented clinical response and absence of disease progression. Submit renewal requests 2-4 weeks before your current authorization expires through the UHC provider portal or by calling 866-889-8054.